Neogen Cuts Jobs as 1Q Revenue Falls

Dow Jones
Oct 09
 

By Nicholas G. Miller

 

Neogen reported lower first-quarter revenue and adjusted profit, and said it had undertaken cost-cutting initiatives, including layoffs, in order to improve margins.

The food and animal safety company reported revenue of $209.2 million, down from $217 million the previous year. Wall Street had expected $203.1 million, according to FactSet.

Revenue from Neogen's food safety segment fell 4.6% to $152.1 million. The company previously said the business had struggled from elevated trade uncertainty and the effect of four years of inflation on food production.

Adjusted net income fell to 4 cents a share, in line with analysts' expectations, but down from 7 cents a share the year prior.

The company said it had taken actions to cut costs at the end of September. "We recently implemented company-wide cost initiatives, which included the difficult decision to reduce headcount across the organization," said Chief Executive Mike Nassif. "These steps will fuel margin growth and give us the ability to strategically reinvest in high-potential areas."

Shares rose 10% to $6.40 in premarket trading.

Neogen reaffirmed its fiscal-year revenue outlook of $820 million to $840 million. Analysts see $815.3 million.

 

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

 

(END) Dow Jones Newswires

October 09, 2025 07:19 ET (11:19 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10